Nagpur
+919405117673
+919405117673

Imatinib 400 mg Tablets – Trusted Global Exporter from India | Fast Delivery to USA, UK, UAE & More

Imatinib 400 mg Tablets by Cordium Pharmaceuticals Pvt Ltd – Reliable Cancer Treatment Export Worldwide Imatinib 400 mg Tablets are widely prescribed for the treatment of certain types of cancer, especially blood-related cancers. Cordium Pharmaceuticals Pvt Ltd, a leading global exporter based in India, ensures the highest quality standards with fast and secure delivery to countries including the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil. What is Imatinib 400 mg Used For? Imatinib belongs to a class of medications known as tyrosine kinase inhibitors (TKIs). It works by blocking abnormal proteins that signal cancer cells to multiply. Common Uses: Chronic Myeloid Leukemia (CML) Acute Lymphoblastic Leukemia (ALL) Gastrointestinal Stromal Tumors (GISTs) Myelodysplastic/Myeloproliferative Diseases Recommended Dosage The usual starting dose is 400 mg once daily, taken with food and a full glass of water. Dosage may vary depending on the condition and patient response. Always follow the prescription provided by a healthcare professional. ⚠️ Do not self-medicate or alter dosage without medical advice. Possible Side Effects Like all medications, Imatinib may cause side effects. Most are manageable but require attention. Common Side Effects: Nausea and vomiting Muscle cramps Fatigue Diarrhea Skin rash Serious Side Effects (Seek medical help): Severe fluid retention Liver problems Low blood cell counts Heart-related issues Why Choose Cordium Pharmaceuticals Pvt Ltd? Trusted global pharmaceutical exporter from India High-quality, WHO-GMP compliant products Competitive pricing for bulk orders Fast international delivery with secure packaging Reliable customer support for global clients 📦 Export Destinations: USA, UK, Germany, Netherlands, South Africa, UAE, Brazil 📞 Contact Now for Bulk Orders & Enquiries: WhatsApp: +91-9405117673 Email: info@cordiumpharma.com
 2026-04-18T14:25:20

Keywords